Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219098 · ClinicalTrials.gov registry record · NA
Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)
A NA study, sponsored by Anne Arundel Health System Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT04219098 is a NA study that has completed, run by Anne Arundel Health System Research Institute. The registered enrollment target is 75 participants.
The verdict
NCT04219098, a NA study, has completed, sponsored by Anne Arundel Health System Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.
Interventions
- OTHER Standard of Care
- PROCEDURE Butterfly IQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2021-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04219098
The ClinicalTrials.gov registry entry for NCT04219098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anne Arundel Health System Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04219098 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04219098 about?
NCT04219098 is a clinical study titled "Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)". The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.
What is the current status of trial NCT04219098?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-02-01. Estimated completion is 2021-08-30.
What interventions are being tested in trial NCT04219098?
The interventions under investigation include: Standard of Care (OTHER), Butterfly IQ (PROCEDURE).
Who is sponsoring clinical trial NCT04219098?
This trial is sponsored by Anne Arundel Health System Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.